Li L - Search Results

1

Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy.

Yang Y, Nian S, Li L, Wen X, Liu Q, Zhang B, Lan Y, Yuan Q, Ye Y. Yang Y, et al. Among authors: li l. Bioengineered. 2021 Dec;12(2):10379-10400. doi: 10.1080/21655979.2021.1996807. Bioengineered. 2021. PMID: 34709992 Free PMC article.

2

Dynamic monitoring of immune function indexes in COVID-19 patients.

Song Y, Zhong H, Li L, Yin M, Yin Y, Guo X, Zhang B, Liu W. Song Y, et al. Among authors: li l. Aging (Albany NY). 2020 Dec 23;12(24):24596-24603. doi: 10.18632/aging.202362. Epub 2020 Dec 23. Aging (Albany NY). 2020. PMID: 33361525 Free PMC article.

3

The endogenous factors affecting the detection of serum SARS-CoV-2 IgG/IgM antibodies by ELISA.

Liu W, Long X, Wan K, Yin M, Yin Y, Zhang B, Li L, Song Y. Liu W, et al. Among authors: li l. J Med Virol. 2022 May;94(5):1976-1982. doi: 10.1002/jmv.27557. Epub 2022 Jan 7. J Med Virol. 2022. PMID: 34967441 Free PMC article.

4

The onset, development and pathogenesis of severe neutrophilic asthma.

Zhang X, Xu Z, Wen X, Huang G, Nian S, Li L, Guo X, Ye Y, Yuan Q. Zhang X, et al. Among authors: li l. Immunol Cell Biol. 2022 Mar;100(3):144-159. doi: 10.1111/imcb.12522. Epub 2022 Feb 16. Immunol Cell Biol. 2022. PMID: 35080788 Review.

5

Changes in the phenotype and function of mucosal-associated invariant T cells in neutrophilic asthma.

Wen X, Nian S, Wei G, Kang P, Yang Y, Li L, Ye Y, Zhang L, Wang S, Yuan Q. Wen X, et al. Among authors: li l. Int Immunopharmacol. 2022 May;106:108606. doi: 10.1016/j.intimp.2022.108606. Epub 2022 Feb 15. Int Immunopharmacol. 2022. PMID: 35180624

6

EphA2 recognizes Dermatophagoidespteronyssinus to mediate airway inflammation in asthma.

Xu Z, Ye Y, Huang G, Li Y, Guo X, Li L, Wu Y, Xu W, Nian S, Yuan Q. Xu Z, et al. Among authors: li y, li l. Int Immunopharmacol. 2022 Oct;111:109106. doi: 10.1016/j.intimp.2022.109106. Epub 2022 Aug 12. Int Immunopharmacol. 2022. PMID: 35969898

7

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker.

Yang Y, Liu Q, Guo X, Yuan Q, Nian S, Kang P, Xu Z, Li L, Ye Y. Yang Y, et al. Among authors: li l. J Oncol. 2022 Aug 31;2022:8115474. doi: 10.1155/2022/8115474. eCollection 2022. J Oncol. 2022. PMID: 36090896 Free PMC article.

8

Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer.

Zhang L, Zhang B, Li L, Ye Y, Wu Y, Yuan Q, Xu W, Wen X, Guo X, Nian S. Zhang L, et al. Among authors: li l. J Cancer Res Clin Oncol. 2023 May;149(5):2243-2258. doi: 10.1007/s00432-022-04326-1. Epub 2022 Sep 15. J Cancer Res Clin Oncol. 2023. PMID: 36107246 Review.

9

Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade.

Kang P, Liu D, Li L, Guo X, Ye Y, Li Y, Jiang Q, Lin S, Yuan Q. Kang P, et al. Among authors: li y, li l. Cytokine. 2023 Mar;163:156133. doi: 10.1016/j.cyto.2023.156133. Epub 2023 Jan 30. Cytokine. 2023. PMID: 36724715

10

Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration.

Li L, Nian S, Liu Q, Zhang B, Jimu W, Li C, Huang Z, Hu Q, Huang Y, Yuan Q. Li L, et al. Among authors: li c. Int Immunopharmacol. 2024 May 10;132:111926. doi: 10.1016/j.intimp.2024.111926. Epub 2024 Mar 28. Int Immunopharmacol. 2024. PMID: 38552297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,914 results

Search Page

Filters